Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print

Industry News

Related Searches:

Filter by:

Merrion, Rebel Enter Feasibility And Option Agreement
December 6, 2010
Merrion Pharmaceuticals has entered an oral drug delivery feasibility and option agreement with Rebel Pharmaceuticals, LLC to evaluate the ability of its GIPET technology to boost the bioavailablity of three undisclosed compounds.   Read More »
Baxter, Takeda Enter Flu Vax Pact In Japan
December 2, 2010
Baxter International and Takeda Pharmaceutical Co. Ltd. have entered a development, license and technology transfer agreement to bring Vero cell culture-based influenza vaccines to the Japanese market.   Read More »
Novartis Restructures, Cuts U.S. Jobs
December 1, 2010
Novartis will cut 1,400 jobs in the U.S. as part of a restructuring effort to streamline its business and to focus on specialty medicines.   Read More »
Axcan To Acquire Eurand
December 1, 2010
Axcan Holdings will acquire all outstanding shares of Eurand for approximately $583 million in cash.   Read More »
DPT Manager Elected To DCAT Board
December 1, 2010
Pam Tyler, a purchasing manager at DPT Laboratories, was recently recognized by the Drug, Chemical and Associated Technology Association (DCAT) for her service to the organization.   Read More »
RiconPharma Acquires NJ Manufacturing Facility
November 30, 2010
RiconPharma has acquired a cGMP pharmaceutical manufacturing company in Fairfield, NJ to be called Mirror Pharmaceuticals LLC.   Read More »
Almac Adds Late Stage Customization Suite
November 29, 2010
Almac has added a dedicated late stage customization suite to its commercial facilities in Europe.   Read More »
Accentia, Baxter Enter Cytoxan Alliance
November 29, 2010
Accentia Biopharmaceuticals has entered a strategic agreement with Baxter Healthcare providing Accentia the exclusive, worldwide right to purchase Baxter’s cyclophosphamide — marketed under the brand name Cytoxan — for the treatment of a   Read More »
GSK Sells U.S. Penicillin Facility To Dr. Reddy’s
November 24, 2010
GlaxoSmithKline will transfer ownership of its penicillin manufacturing site in Bristol, TN, and rights for the Augmentin and Amoxil brands in the U.S. to Dr. Reddy’s Laboratories.   Read More »
Lancaster Labs Launches New Mycoplasma Assay
November 22, 2010
Lancaster Laboratories has introduced a new cGMP compliant mycoplasma assay, harmonizing both United States Pharmacopeia (USP) Chapter <63> monograph and European Pharmacopoeia Chapter 2.6.7 guidelines.   Read More »
Bayer Cuts Jobs In Restructuring Effort
November 19, 2010
Bayer plans to restructure in order invest its resources in growing the company and enhancing its capabilities.   Read More »
Baxter Acquires Hemophilia Assets From Archemix
November 19, 2010
Baxter has entered into a definitive agreement to acquire all of the hemophilia-related assets of Archemix, a privately-held biopharmaceutical company.   Read More »
Roche To Restructure, Lay Off 4,800
November 17, 2010
Setbacks after Genentech acquisition lead to $2.4 billion cost-cutting   Read More »
Laureate Launches Regulatory Affairs Services
November 12, 2010
Laureate Pharma has established a Regulatory Affairs group and has appointed Robert G. Burford, Ph.D.   Read More »
Emory U. Selects Pilgrim For Clinical Trial Solution
November 12, 2010
Emory University has selected Pilgrim Software to support its clinical trial internal auditing operations.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: